386 filings
Page 19 of 20
8-K
olqf5zg5a6lvommi
7 Oct 05
Entry into a Material Definitive Agreement
12:00am
8-K
ellbajxmztr
30 Aug 05
Unregistered Sales of Equity Securities
12:00am
8-K
8j3th6nmbsqk4m
12 Aug 05
Departure of Directors or Principal Officers
12:00am
8-K
8wzm68je1ehmedlnkz4y
2 Aug 05
Other Events
12:00am
8-K
2i8j6gg4988jp3bvy kv
27 Jul 05
Entry into a Material Definitive Agreement
12:00am
8-K
z4yzu8m
6 Jul 05
Adventrx Joins the New Russell Microcap Index
12:00am
8-K
g08thqvc hdcij1
10 Jun 05
Entry into a Material Definitive Agreement
12:00am
8-K
6v3slz7wnfbslfli
16 May 05
Adventrx Announces 2005 First Quarter Financial Results
12:00am
8-K
xruur54tgknnomyii
2 May 05
ADVENTRX’s Preliminary Results for CoFactor Phase II Trial Published at ASCO
12:00am
8-K
tit h6l4z9a
25 Apr 05
Adventrx Receives Fda Clearance for Cofactor Phase Iii
12:00am
8-K
ni9kl9s7
19 Apr 05
Adventrx Presents Cofactor Toxicity and Pharmacodynamics Data from Phase Ii Trial
12:00am
8-K
oru5i
15 Apr 05
Adventrx Granted Clearance In the Uk for Cofactor Phase Iib
12:00am
8-K
tm333311 z7c90pj0
11 Apr 05
Adventrx’s Cofactor Phase Ii and Preclinical Toxicity Data to Be Presented at Aacr Annual Meeting
12:00am
8-K
qfwqa6jr fut3z1b42u5
5 Apr 05
CORRECTING and REPLACING ADVENTRX ANNOUNCES 2004 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
12:00am
8-K
gols2m1
30 Mar 05
Adventrx Receives Cofactor Pancreatic Cancer Clinical
12:00am
8-K
eb0ov12hr bhhn5l
7 Mar 05
Adventrx Announces Primary Endpoint
12:00am
8-K
62i 2wifb9jvo8
26 Jan 05
Other Events
12:00am
8-K
90q61cr
13 Dec 04
ADVENTRX Pharmaceuticals Announces Senior Management
12:00am
8-K
4xt 0qvf6ptk47
15 Nov 04
ADVENTRX Pharmaceuticals Announces Third Quarter 2004 Results
12:00am
8-K
vemku2lxckzji
3 Nov 04
FDA Clears CoFactorTM to Begin Second Stage of Phase II Clinical Trial for Metastatic Colorectal Cancer
12:00am